2014
DOI: 10.1016/j.neulet.2014.03.040
|View full text |Cite
|
Sign up to set email alerts
|

The progestin etonogestrel enhances the respiratory response to metabolic acidosis in newborn rats. Evidence for a mechanism involving supramedullary structures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
24
2

Year Published

2014
2014
2022
2022

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 15 publications
(31 citation statements)
references
References 34 publications
5
24
2
Order By: Relevance
“…To conclude, DSG has been associated with chemosensitivity recovery in CCHS patients (Straus et al, 2010). Its metabolite, ETO, has been shown to enhance chemosensitivity in newborn rats via supramedullary mechanisms (Loiseau et al, 2014). Combined with the present data, these observations suggest that two distinct pathways are involved in the ventilatory effects of these gonane progestins.…”
Section: Resultssupporting
confidence: 69%
See 1 more Smart Citation
“…To conclude, DSG has been associated with chemosensitivity recovery in CCHS patients (Straus et al, 2010). Its metabolite, ETO, has been shown to enhance chemosensitivity in newborn rats via supramedullary mechanisms (Loiseau et al, 2014). Combined with the present data, these observations suggest that two distinct pathways are involved in the ventilatory effects of these gonane progestins.…”
Section: Resultssupporting
confidence: 69%
“…A better understanding of the mechanisms of action of DSG and ETO on breathing command and regulation is fundamental to evaluate the conditions under which these progestins could be used to treat patients with central hypoventilation. In this context, we recently showed, in rodents, that ETO enhances the ventilatory response to metabolic acidosis by a mechanism involving supramedullary structures (Loiseau et al, 2014). Whether or not DSG and ETO interfere with generation of the respiratory rhythm (namely resting ventilation) is currently unknown.…”
Section: A C C E P T E D Accepted Manuscriptmentioning
confidence: 99%
“…While the effects of progesterone on peripheral chemoreceptors would suggest that it increases hypoxic ventilatory response, in adult female rats treated with estradiol + progesterone minute ventilation increases [32], [34], but the effects on hypoxic ventilatory response were small [32]. In adult male rats, progesterone + estradiol treatment increases minute ventilation and hypercapnic ventilatory response [35], and etenogestrel (a potent progesterone receptor agonist) enhances response to metabolic acidosis on in-vitro preparation of the central nervous system in newborn rats [36]. Accordingly, the available findings indicate that in adults progesterone mainly increases ventilation under hypercapnic condition, our data indicate that this effects is mediated by the nuclear progesterone receptor.…”
Section: Discussionmentioning
confidence: 99%
“…One putative structure is the nucleus of the solitary tract (NTS), which expresses Phox2b in adult rats, is not affected by Phox2b poly-alanine mutations, and contains neurons that are inhibited by hypoxia but whose activity is restored by progesterone administration [34,[44][45][46]. Consistently, neurons in the commissural part of the NTS are activated by 3-KDG [15,20]. C1 neurons may also be involved in the recovery of the two CCHS patients as PHOX2B has been identified in selected populations of TH-expressing neurons in adult rats, including the C1 neurons [44] that regulate the breathing network at multiple levels [47,48].…”
Section: -Kdg Modulates Phox2b Gene Expression Via Progesterone Nucmentioning
confidence: 99%
“…Progesterone exerts its biological effects by binding nuclear or membrane progesterone receptors, and recent data provide evidence that nuclear receptors are important modulators of respiratory control during sleep and chemoreflex sensitivity: adult female mice from which the nuclear receptor has been deleted show more frequent sighs and post-sigh apnea during non-REM sleep, and reduced responses to hypercapnia after chronic progesterone treatment [19]. Although the exact molecular mechanism of the pharmacological effect of desogestrel is unknown, recent evidence indicates that multiple pathways, involving both medullary and supramedullary neurons, may play a role in the ventilatory effects of desogestrel [15,20]. It is also worth noting that a number of rodent brain structures (including some expressing Phox2b in adulthood) are activated by desogestrel and the same structures may be involved in the recovery observed in the two CCHS patients; however, the contribution of PHOX2B and its mutations to respiratory improvement has not yet been investigated.…”
Section: Introductionmentioning
confidence: 99%